Becton, Dickinson and Company (BMV:BDX)

Market Cap	950.76B
Revenue (ttm)	403.30B
Net Income (ttm)	29.89B
Shares Out	n/a
EPS (ttm)	103.16
PE Ratio	31.81
Forward PE	12.39
Dividend	81.51 (2.41%)
Ex-Dividend Date	Sep 8, 2025

Volume	245
Average Volume	717
Open	3,389.40
Previous Close	3,275.00
Day's Range	3,389.40 - 3,389.40
52-Week Range	3,275.00 - 4,815.00
Beta	n/a
RSI	33.66
Earnings Date	Nov 6, 2025

About BMV:BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1897
• Employees: 74,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: BDX

Financial Performance

In 2024, BMV:BDX's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.

Financial numbers in USD